Literature DB >> 32675926

Relationship between Left Ventricular Outflow Tract Pressure Gradient and Hemoglobin in Patients with Hypertrophic Cardiomyopathy.

Yangyi Lin1, Lisha Yu2, Fangfei Liu3, Xiongying Lin4, Hongsong Li1, Xiangdong Xu1.   

Abstract

BACKGROUND: Anemia caused by left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy (HOCM) has been reported, however, large clinical studies confirming this association are lacking. The objective of the present study was to investigate the relationship between left ventricular outflow tract (LVOT) pressure gradient and hemoglobin in patients with hypertrophic cardiomyopathy (HCM).
METHODS: Patient demographics, laboratory and echocardiography data from 310 patients diagnosed with HCM from our hospital who had undergone echocardiography from July 2014 to March 2019 were collected from medical records. Patients were classified into HOCM and non-HOCM groups.
RESULTS: Compared to the non-HOCM group, patients in the HOCM group had a lower hemoglobin level (112.2 ± 16.7 vs. 132.9 ± 22.2 g/L, p < 0.001). In addition, significant negative correlations between hemoglobin and LVOT pressure gradient were found in males (r = -0.568, p < 0.001) and females (r = -0.589, p < 0.001). Receiver operating characteristic curve analysis revealed that the best cut-off value for hemoglobin to predict HOCM in male patients was 128 g/L with 74.19% sensitivity and 75.51% specificity (area under the curve: 0.763, p < 0.001). For female patients, the cut-off value was 125 g/L, with a sensitivity and specificity of 89.39% and 48.48%, respectively (area under the curve: 0.718, p < 0.001).
CONCLUSIONS: Our results indicate that hemoglobin level is inversely proportional to the LVOT gradient pressure and has value for predicting outflow tract obstruction in patients with HCM.

Entities:  

Keywords:  Bernoulli equation; Continuity equation; Dynamic obstruction; Hemolytic anemia; Left ventricular outflow tract pressure gradient

Year:  2020        PMID: 32675926      PMCID: PMC7355115          DOI: 10.6515/ACS.202007_36(4).20191206A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  20 in total

1.  Severe hemolytic anemia in hypertrophic cardiomyopathy.

Authors:  S Peláez-Dominguez; L Pérez-Benito; J Sanz Moreno; I García Calvo; J Ruiz Morales; A Palomo Bravo
Journal:  Am Heart J       Date:  1992-10       Impact factor: 4.749

2.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

Authors:  Constantinos O'Mahony; Fatima Jichi; Menelaos Pavlou; Lorenzo Monserrat; Aristides Anastasakis; Claudio Rapezzi; Elena Biagini; Juan Ramon Gimeno; Giuseppe Limongelli; William J McKenna; Rumana Z Omar; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-10-14       Impact factor: 29.983

3.  Shear-Induced Hemolysis: Species Differences.

Authors:  Jun Ding; Shuqiong Niu; Zengsheng Chen; Tao Zhang; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2015-04-20       Impact factor: 3.094

Review 4.  New perspectives on the prevalence of hypertrophic cardiomyopathy.

Authors:  Christopher Semsarian; Jodie Ingles; Martin S Maron; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2015-03-31       Impact factor: 24.094

5.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

6.  Dramatic improvement of refractory anemia caused by mechanical hemolysis in a patient with hypertrophic obstructive cardiomyopathy using dual-chamber pacing.

Authors:  Yosuke Miwa; Kyoko Soejima; Toshiaki Sato; Kenichi Matsushita; Junsuke Sueoka; Nobuyuki Takayama; Hideaki Yoshino
Journal:  J Arrhythm       Date:  2015-01-02

7.  Chronic haemolytic anaemia in hypertrophic cardiomyopathy.

Authors:  A Zezulka; L Shapiro; S Singh
Journal:  Br Heart J       Date:  1984-10

8.  Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005.

Authors:  Erin McLean; Mary Cogswell; Ines Egli; Daniel Wojdyla; Bruno de Benoist
Journal:  Public Health Nutr       Date:  2008-05-23       Impact factor: 4.022

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  Effect of Heart Rate-Oriented Therapy on Diastolic Functions in Patients with Heart Failure with Reduced Ejection Fraction.

Authors:  Sedat Taş; Ümmü Taş; Ebru Özpelit; Efe Edem; Bahri Akdeniz
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.